| Centro De Salud De La Comunidad De San Ysidro Inc | |
|
3291 Buckman Springs Rd Pine Valley CA 91962-4003 | |
| (619) 662-4100 | |
| Not Available |
| Full Name | Centro De Salud De La Comunidad De San Ysidro Inc |
|---|---|
| Speciality | Clinic/center - Federally Qualified Health Center (fqhc) |
| Location | 3291 Buckman Springs Rd, Pine Valley, California |
| Authorized Official Name and Position | William Brian Wallace (VP/CFO) |
| Authorized Official Contact | 6192056339 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Centro De Salud De La Comunidad De San Ysidro Inc 1601 Precision Park Ln San Diego CA 92173-1345 Ph: (619) 205-6349 | Centro De Salud De La Comunidad De San Ysidro Inc 3291 Buckman Springs Rd Pine Valley CA 91962-4003 Ph: (619) 662-4100 |
| NPI Number | 1770117814 |
|---|---|
| Provider Enumeration Date | 02/27/2020 |
| Last Update Date | 02/27/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770117814 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Rutgers and other scientists have discovered how brown fat, also known as brown adipose tissue, may help protect against obesity and diabetes.
A new study shows that people with multiple sclerosis may be at a lower risk for cancer overall, but at a higher risk of developing certain types of cancer, such as brain tumors and bladder cancer.
A study in the Feb. 15 issue of the Journal of Clinical Sleep Medicine found that poor sleep quality correlated with higher levels of depressive symptoms, greater pain severity, increased fatigue, and greater functional disability in patients with Rheumatoid Arthritis.
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
› Verified 4 days ago
Mountain Empire School Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3291 Buckman Springs Rd, Pine Valley, CA 91962 Phone: 619-473-8601 Fax: 619-478-2267 |